Total Payments
$92,928
2024 Payments
$117.23
Companies
24
Transactions
181
Medicare Patients
4,546
Medicare Billing
$562,152
Payment Breakdown by Category
Other$64,015 (68.9%)
Consulting$14,658 (15.8%)
Travel$9,230 (9.9%)
Food & Beverage$5,023 (5.4%)
Education$2.69 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,815 | 21 | 62.2% |
| Consulting Fee | $14,658 | 6 | 15.8% |
| Travel and Lodging | $9,230 | 43 | 9.9% |
| Food and Beverage | $5,023 | 108 | 5.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,400 | 1 | 4.7% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $1,800 | 1 | 1.9% |
| Education | $2.69 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $78,718 | 112 | $0 (2022) |
| Cook Incorporated | $6,254 | 3 | $0 (2019) |
| Pulmonx Corporation | $3,313 | 4 | $0 (2019) |
| Pinnacle Biologics, Inc | $2,357 | 10 | $0 (2021) |
| Noah Medical Corporation | $1,028 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $223.15 | 6 | $0 (2024) |
| Galderma Laboratories, L.P. | $204.81 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $200.25 | 12 | $0 (2024) |
| Genentech USA, Inc. | $125.00 | 1 | $0 (2019) |
| GENZYME CORPORATION | $111.38 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.23 | 5 | Shionogi Inc ($56.87) |
| 2023 | $1,183 | 8 | Noah Medical Corporation ($1,028) |
| 2022 | $5,188 | 14 | Boston Scientific Corporation ($4,916) |
| 2021 | $340.38 | 8 | BOSTON SCIENTIFIC CORPORATION ($230.15) |
| 2020 | $34.64 | 2 | Cook Medical LLC ($18.33) |
| 2019 | $7,819 | 14 | Cook Incorporated ($4,400) |
| 2018 | $19,824 | 37 | BOSTON SCIENTIFIC CORPORATION ($17,143) |
| 2017 | $58,421 | 93 | BOSTON SCIENTIFIC CORPORATION ($56,313) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Insomnia | ||||||
| 08/28/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: RESPIRATORY | ||||||
| 04/17/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Respiratory | ||||||
| 11/27/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: PAH | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: PAH | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2023 | Noah Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $1,028.29 | General |
| Category: Critical Care Medicine | ||||||
| 03/02/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $12.93 | General |
| 02/07/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Respiratory | ||||||
| 09/13/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Immunology | ||||||
| 09/07/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Respiratory | ||||||
| 06/03/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $11.19 | General |
| 05/26/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 04/27/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.22 | General |
| Category: Respiratory | ||||||
| 04/12/2022 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: Medical Device | ||||||
| 04/01/2022 | Boston Scientific Corporation | General - Pulmonary (Device) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: General - Pulmonary_ENDO | ||||||
| 04/01/2022 | Boston Scientific Corporation | General - Pulmonary (Device) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: General - Pulmonary_ENDO | ||||||
| 04/01/2022 | Boston Scientific Corporation | General - Pulmonary (Device) | Travel and Lodging | Cash or cash equivalent | $171.58 | General |
| Category: General - Pulmonary_ENDO | ||||||
| 04/01/2022 | Boston Scientific Corporation | General - Pulmonary (Device) | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: General - Pulmonary_ENDO | ||||||
| 04/01/2022 | Boston Scientific Corporation | General - Pulmonary (Device) | Food and Beverage | Cash or cash equivalent | $24.95 | General |
| Category: General - Pulmonary_ENDO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,027 | 1,319 | $567,789 | $126,404 |
| 2022 | 23 | 1,082 | 1,407 | $586,206 | $133,179 |
| 2021 | 23 | 1,181 | 1,499 | $583,232 | $141,979 |
| 2020 | 30 | 1,256 | 1,670 | $702,881 | $160,590 |
Total Patients
4,546
Total Services
5,895
Medicare Billing
$562,152
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 299 | $90,896 | $30,793 | 33.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 90 | 127 | $51,435 | $19,169 | 37.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 153 | $43,758 | $15,550 | 35.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 52 | 63 | $48,195 | $11,639 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 59 | 59 | $34,161 | $9,979 | 29.2% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Office | 2023 | 13 | 22 | $29,194 | $6,526 | 22.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 93 | 100 | $18,100 | $5,032 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 63 | $12,978 | $4,444 | 34.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 82 | 88 | $15,928 | $4,331 | 27.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 48 | 51 | $46,257 | $2,965 | 6.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $8,976 | $2,414 | 26.9% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 17 | 24 | $31,848 | $2,164 | 6.8% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 22 | 23 | $25,162 | $2,138 | 8.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 64 | 68 | $7,208 | $1,657 | 23.0% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 13 | 15 | $26,190 | $1,596 | 6.1% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 11 | 13 | $11,869 | $1,478 | 12.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 31 | 32 | $5,728 | $1,157 | 20.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 16 | $3,184 | $1,045 | 32.8% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 11 | 11 | $42,988 | $902.11 | 2.1% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 12 | 13 | $4,095 | $737.62 | 18.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 56 | 63 | $9,639 | $687.33 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 306 | $93,024 | $31,902 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 75 | 92 | $37,260 | $13,708 | 36.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 80 | 152 | $43,472 | $13,499 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 60 | 60 | $34,740 | $11,201 | 32.2% |
About Dr. David Duhamel, MD
Dr. David Duhamel, MD is a Pulmonary Disease healthcare provider based in Arlington, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609869932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Duhamel, MD has received a total of $92,928 in payments from pharmaceutical and medical device companies, with $117.23 received in 2024. These payments were reported across 181 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,815).
As a Medicare-enrolled provider, Duhamel has provided services to 4,546 Medicare beneficiaries, totaling 5,895 services with total Medicare billing of $562,152. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Arlington, VA
- Active Since 08/23/2005
- Last Updated 08/04/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1609869932
Products in Payments
- ALAIR (Device) $37,939
- ALAIR BRONCHIAL THERMOPLASTY SYSTEM (Device) $7,269
- Cook Medical Percutaneous Tracheostomy (Device) $6,200
- General - Pulmonary (Device) $4,916
- GENERAL PULMONARY (Device) $4,795
- ULTRAFLEX ESOPHAGEAL NG STENT SYSTEM (Device) $4,196
- ACQUIRE (Device) $3,366
- GENERAL - THERAPIES (Device) $3,325
- Pulmonx Endobronchial Valve EBV (Device) $3,313
- EXPECT (Device) $3,219
- GENERAL BRONCHIAL THERMOPLASTY (Device) $2,679
- GENERAL - PULMONARY (Device) $2,408
- Photofrin (Drug) $2,357
- GENERAL - BRONCHIAL THERMOPLASTY (Device) $2,156
- OTHER- BSC PRODUCT NOT LISTED (Device) $1,653
- GENERAL THERAPIES (Device) $427.50
- GENERAL PULMONARY (Device) $230.15
- BREZTRI (Drug) $183.31
- Esbriet (Biological) $125.00
- DUPIXENT (Biological) $111.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Arlington
Jeff Hales, Md, MD
Pulmonary Disease — Payments: $29,884
Pulmonary Disease $29,884
Michael Makary, Md, MD
Pulmonary Disease — Payments: $9,181
Pulmonary Disease $9,181
Phan Nguyen, Md, MD
Pulmonary Disease — Payments: $4,020
Pulmonary Disease $4,020
Richard Sappington, M.d, M.D
Pulmonary Disease — Payments: $1,330
Pulmonary Disease $1,330
Dr. Samantapudi Daya, Md, MD
Pulmonary Disease — Payments: $1,026
Pulmonary Disease $1,026
Dr. David Plump, M.d, M.D
Pulmonary Disease — Payments: $392.78
Pulmonary Disease $392.78